Your browser doesn't support javascript.
Nirmatrelvir-ritonavir for COVID-19: CMAJ
Canadian Medical Association. Journal ; 194(6):218, 2022.
Article in English | ProQuest Central | ID: covidwho-1695685
ABSTRACT
McDonald and Lee present several facts about nirmatrelvir-ritonavir. Ritonavir-boosted nirmatrelvir is a Health Canada-approved oral antiviral medication with activity against SARS-CoV-2 Treatment is indicated for adult (≥ 18 yr) outpatients with nonhypoxic COVID-19 who are at high risk of severe disease progression.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Canadian Medical Association. Journal Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Canadian Medical Association. Journal Year: 2022 Document Type: Article